September 21, 2017 3:51 AM ET

Pharmaceuticals

Company Overview of U3 Pharma GmbH

U3 Pharma GmbH INSIDERS ON Board Members

Name (Connections)RelationshipsTitleAge
Axel Ullrich Ph.D. 36 RelationshipsScientific Founder and Director73

Other Board Members on Board Members

Name (Connections)RelationshipsType of Board MembersPrimary CompanyAge
Junichi Koga 11 RelationshipsMember of Supervisory BoardDaiichi Sankyo Company, Limited--
Joël Besse 15 RelationshipsMember of the Board of DirectorsOrion Healthcare Equity Partners52
Joachim Rothe Ph.D.43 RelationshipsMember of the Board of DirectorsLife Sciences Partners BV53
Martin Hesse 5 RelationshipsMember of Supervisory BoardDaiichi Sankyo Europe GmbH52
Kenji Katsumi 5 RelationshipsMember of Supervisory BoardDaiichi Sankyo Company, Limited--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Connected People on the U3 Pharma GmbH Board

NameRelationships
Joachim Rothe Ph.D.43 Relationships
Axel Ullrich Ph.D.36 Relationships
Joël Besse 15 Relationships
Junichi Koga 11 Relationships
Kenji Katsumi 5 Relationships

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact U3 Pharma GmbH, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.